Literature DB >> 10810289

Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6.

J J Bond1, S Meka, R C Baxter.   

Abstract

Many tumours secrete IGF-II in incompletely processed precursor forms. The ability of these pro-IGF-II forms to complex with the six IGF binding proteins (IGFBPs) is poorly understood. In this study, pro-IGF-II has been extracted from the serum and tumour tissue of two patients with non-islet cell tumour hypoglycaemia. These samples were used to study binary complex formation with IGFBPs-1 to -6 using competitive IGF-II binding assays and ternary complex formation with IGFBP-3 and IGFBP-5. In each case, IGFBPs-1 to -6 showed little difference in their ability to form binary complexes with recombinant IGF-II or tumour-derived pro-IGF-II forms, when the preparations were standardised according to IGF-II immunoreactivity. As previously described, ternary complex formation by acid-labile subunit (ALS) with IGFBP-3 and pro-IGF-II was greatly decreased compared with complex formation with mature IGF-II. In contrast, ALS bound similarly to IGFBP-5 in the presence of pro-IGF-II and mature IGF-II. These studies suggest that pro-IGF-II preferentially forms binary complexes with IGFBPs, and ternary complexes with IGFBP-5, rather than ternary complexes with IGFBP-3 as seen predominantly in normal serum. This may increase the tissue availability of serum pro-IGF-II, allowing its insulin-like potential to be realised.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10810289     DOI: 10.1677/joe.0.1650253

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  15 in total

1.  Plasma distribution and signaling activities of IGF-II precursors.

Authors:  Alicia G Marks; Julie M Carroll; Jonathan Q Purnell; Charles T Roberts
Journal:  Endocrinology       Date:  2011-02-01       Impact factor: 4.736

2.  Fibrinous tumor of the pleura: an orphan disease lost in translation.

Authors:  Paul Zarogoulidis; Vasiliki Draba; Nikolaos Machairiotis; Katerina Manika; Dimitrios Mikroulis; Kosmas Tsakiridis; Nikolaos Courcoutsakis; Ioannis Kioumis; Athanasios Zissimopoulos; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2012-10       Impact factor: 2.895

3.  Biochemical characterization of individual human glycosylated pro-insulin-like growth factor (IGF)-II and big-IGF-II isoforms associated with cancer.

Authors:  Sameer A Greenall; John D Bentley; Lesley A Pearce; Judith A Scoble; Lindsay G Sparrow; Nicola A Bartone; Xiaowen Xiao; Robert C Baxter; Leah J Cosgrove; Timothy E Adams
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

4.  Bioactive insulin-like growth factors as a possible molecular target for non-islet cell tumor hypoglycemia.

Authors:  Takeshi Setoyama; Shin'ichi Miyamoto; Takahiro Horimatsu; Taro Funakoshi; Mitsuhiro Nikaido; Yuzo Kodama; Sachiko Minamiguchi; Tomoko Yamabata; Manabu Muto; Tsutomu Chiba
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

5.  Early Improvement of Non-islet Cell Tumor Hypoglycemia by Chemotherapy Using Lenvatinib in a Case with Type 2 Diabetes and Hepatocellular Carcinoma Producing Big IGF-II.

Authors:  Takuma Izutsu; Hiroyuki Ito; Izumi Fukuda; Hideki Tamura; Suzuko Matsumoto; Shinichi Antoku; Toshiko Mori; Hiroaki Goto
Journal:  Intern Med       Date:  2020-11-30       Impact factor: 1.271

6.  Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer.

Authors:  Seung Tae Kim; Hye-Lim Jang; Jeeyun Lee; Se Hoon Park; Young Suk Park; Ho Yeong Lim; Min Gew Choi; Jae Moon Bae; Tae Sung Sohn; Jae Hyung Noh; Sung Kim; Kyoung-Mee Kim; Won Ki Kang; Joon Oh Park
Journal:  Transl Oncol       Date:  2015-08       Impact factor: 4.243

Review 7.  Surgically cured hypoglycemia secondary to pleural solitary fibrous tumour: case report and update review on the Doege-Potter syndrome.

Authors:  Ahmed Y Kalebi; Martin J Hale; Michelle L Wong; Tessa Hoffman; Jill Murray
Journal:  J Cardiothorac Surg       Date:  2009-08-18       Impact factor: 1.637

8.  Non-islet cell tumor hypoglycemia caused by intrathoracic solitary fibrous tumor: a case report.

Authors:  Masahiro Kitada; Shunsuke Yasuda; Nana Takahashi; Satoshi Okazaki; Kei Ishibashi; Satoshi Hayashi; Yoshinobu Ohsaki; Naoyuki Miyokawa
Journal:  J Cardiothorac Surg       Date:  2016-04-09       Impact factor: 1.637

9.  Doege-Potter Syndrome, cause of nonislet cell tumor hypoglycemia: the first case report from Nepal.

Authors:  Vivek Pant; Suman Baral; Gita Sayami; Prakash Sayami
Journal:  Int Med Case Rep J       Date:  2017-08-16

10.  Pro-IGF2-induced hypoglycaemia associated with hepatocellular carcinoma.

Authors:  S A A van den Berg; C G Krol
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.